Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Sebastian

Sebastian

Oltean University of Bristol UK

Qiang Tu

Qiang Tu

Flinders University Australia

Peter Decock

Peter Decock

Cargill Research & Development Center Belgium

Yousuf Shaheen

Yousuf Shaheen

United Nations Relief and Works Agency Jordan

Edyta Gendaszewska-Darmach

Edyta Gendaszewska-Darmach

Lodz University of Technology Poland

Małgorzata Zakłos-Szyda Lodz

Małgorzata Zakłos-Szyda Lodz

University of Technology Poland

 Raffaella Mastrocola

Raffaella Mastrocola

University of Torino Italy

Massimo Collino

Massimo Collino

University of Turin Italy

Diabetes Global 2018

About Conference


Hear Explore and learn the latest research. Present before distinguished global audience. Collaborate, build partnerships and experience Europe. Join the global academic community.

Welcome to the Diabetes Global 2018!

The exciting and innovative program brought together national and international experts to promote the exchange of the latest clinical practices and cutting edge research in diabetes. State-of-the-Art lectures, free communication sessions and clinical and scientific educational symposia, were appreciated by the 2017 attendees. With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce 17th Global Diabetes Conference & Nursing Care (Diabetes Global 2018) as a continuum of our previous successful conference. Diabetes Global 2018 will be held in Paris, France during March 08-09, 2018. The conference will focus on Applying Science and Technology to Fight Diabetes.

The program organizing committee consists of members from all three societies and endeavors to present you with the latest and most exciting data from these respective fields with a range of international and national leading speakers. The benefits of this large scale collaborative meeting include: broader content areas, efficiency in meeting attendance and costs for delegates and trade partners, a more diverse variety of sessions, and increased attendees. Our scientific program includes invited plenary presentations, symposia and seminars, meet-the-professor sessions, basic and clinical abstract presentations, young investigator awards, and interactive poster sessions. Our speakers are drawn from a truly international profile, with themes in contemporary Diabetes and its related disorders and Therapies.

Benefits of Attending:

  • Exchange ideas and network with leading diabetologists, endocrinologists, diabetes researchers, clinicians researchers, diabetes and endocrinology professionals and researchers from more than 40 countries
  • Discuss quality initiatives that can be applied in the practice
  • Discuss ways to collaborate in putting quality initiatives in place throughout the diabetes study and endocrinology and diabetes disorders and treatment
  • Participants can gain direct access to a core audience of professionals and decision makers and can increase visibility through branding and networking at the conference
  • Learn and discuss key news and challenges with senior level speakers.
  • With presentations, panel discussions, roundtable discussions, and workshops, we cover every topic from top to bottom, from global macro issues to strategies to tactical issues

About Hosting Organization: Conference Series Ltd

Conference Series Ltd is the world’s leading specialist in organizing Academic, Scientific and Business conferences, meetings, symposiums and exhibitions in different verticals and horizontals like Medical, Pharma, Engineering, Science, Technology and Business to promote scientific research. Every year we host more than 3000+ global events inclusive of 1000+ Conferences 1000+ Symposiums 1000+ Workshops in USA, Europe, Middle East and Asia with the generous support and cooperation from our 30000+ Editorial Board Members1000+ Scientific Societies. All the conference proceedings are published in the special issues of our 700+ Open Access International Journals with the DOI provided by CROSSREF.

 

Target Audience

Diabetologists

Endocrinologists

Doctors

Researchers

Physicians

Business Professionals

Academic Professionals

Students

Scientists

Medical and Pharma Companies

Medical Colleges and Hospitals

Diabetes Societies and Associations

 

We look forward to seeing you in Paris!

 

Sessions/Tracks

Conference Series Ltd takes immense pleasure to extend our warm welcome to you all to 27th European Diabetes Congress which will be happening in Rome, Italy from June 11-12, 2018 with the theme " New technologies and practical approaches in the field of diabetes and endocrine disorders".

Sessions/Tracks

Track 1: Physiology of diabetes

Pathophysiologic modification is a change in task as notable from a structural defect. Diabetes occurs when there is a dis-balance between the demand and manufacture of the hormone insulin. Pathophysiology of diabetes is that in this circumstance the immune system outbreaks and terminates the beta cells of the pancreas which produce insulin. There is lack of beta cell leading to complete insulin deficiency. Whereas in type 2 diabetes there is comparatively lesser deficiency of insulin and not an complete deficiency. This means that the body is incapable to harvest appropriate insulin to overcome the demand. There is Beta cell deficiency coupled with peripheral insulin resistance. Gestational diabetes is the third type of diabetes. It is caused when there are excessive counter-insulin hormones of pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother. There may be faulty insulin receptors. These part of diabetes study is covered in ADA meetings and IDF word Diabetes Congress

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 2: Diagnosis of Diabetes

Diabetes may be analysed based on plasma and glucose criteria or A1C criteria. Early in disease diabetes shows no symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnostic in diabetes involve taking blood at a healthcare facility centre or commercial diagnostic centre and sending the sample to a lab for examination. To ensure that test results are accurate lab study of blood of required. Glucose calculating devices used in a health care provider’s office, such as finger-stick devices, are not precise enough for analysis but may be used as a rapid indicator of high blood sugar. Such area of research are highly discussed in  ADA annual meeting.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 3: Diabetic Case Studies

Diabetes case reports are in-depth inquiries of an individual, crowd, occasion or public. The data are assembled from a diversity of places by various methods. The case study technique encompasses spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e. the idiographic approach. Case studies permit an investigator to investigate a topic in far more detailed and minute way. The case study is not itself a research method, but investigators choose methods of data collection and analysis that will generate material suitable for case studies. Most of this evidence is likely to be qualitative but the psychologist might collect numerical data as well and present in various diabetes conference and scientific sessions

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 4: Symptoms and Treatment of Diabetes

Diabetes is a severe illness that cannot be cured of its own. Doctor aids to create a diabetes management plan that is right for the patient. Cure for diabetes demands to keep close watch over the blood sugar level with a combination of medications, work out, and diet. Since the spectacular finding in Toronto in 1922 that type 1 diabetes arises from a deficit of insulin. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations. The supervision of diabetes has been decisively grounded in scientific advances that endure to outline our understanding of the pathophysiology of diabetes and direct our choices in choosing optimal therapies for type 1 and type 2 Diabetes. Now, a days we get in market glucose meters which is a modern technology which has the capability to help people living with type 1 or type 2 diabetes and treated with insulin to accomplish the dream of ideal control of blood sugar.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 5: Diabetes in Market

Diabetes trade directs to the 11 largest therapeutic and diagnostic companies producing diabetes related merchandises or those involved with to take diabetes cure to next level. Diabetes is a major issue in the UK, and as such a large healthcare and medical industry has come up like mushroom around it. Aspects such as growing number of diabetic patients across BRIC countries, increasing study on diabetes, and increasing international research collaborations are lashing the growth of the this market. In the European Region there is about 60 million people leaving with diabetes, or about 10.3% of men and 9.6% of women aged 25 years and over. Occurrence of diabetes is growing among all ages in the, typically due to escalations in overweight and obesity, unhealthy diet and less of physical activity.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 6: Complementary and Alternative Medicine

Complementary and alternative medicine is can be well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that are not presently measured to be part of predictable medicine”. Complementary medicine is used with predictable therapy, whereas alternative medicine is used instead of conventional medicine. In CAM therapies diabetes supplement is widely given to the diabetic patients in. Although some of these therapies may be useful, others can be not so useful or even harmful. Contrary reactions of many CAM therapies are not well known because patients with diabetes often take various diabetes medications, there occurs budding for herbal medicine and herb dietary habit supplement interactions, leading to contrary events.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 7: Biomarker for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play a vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 8: Endocrinology

Clinical Endocrinology and metabolism is a field of medicine; more precisely a sub-specialty of internal medicine, which mainly deals with the investigation and management of sicknesses related to hormones. The human endocrine system involves number of glands. These glands harvest and release hormones which monitor many important function of our body. When the hormone exits the gland they reach the bloodstream and are moved to organs and tissues in every part of the body. Endocrinology also concentrates on the endocrine glands and tissues that secrete hormones. The human endocrine system comprises of several glands. These glands harvest and secrete hormones which regulate the body's metabolism, growth, sexual development and function. Hormonal imbalance in our body henceforth leads to diabetes.  

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 9: Diabetes and its Complications

Long-standing complications of diabetes grow progressively. Number of years of having diabetes is directly proportional to the higher risk of complications. Sometimes diabetes complications may be restricting or even lethal. A well-controlled blood sugar have less diabetic complications.  Broader health issues quicken the venomous effects of diabetes which include smoking, higher diabetes cholesterol levels, obesity, high blood pressure, and lack of regular exercise. The best forecaster of type 2 diabetes is overweight or obesity. People who have weight related issues or have obesity have additional pressure on their body's capability to use insulin to properly control blood sugar levels, and are therefore pick up diabetes more easily.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 10: Diabetes and Associated Diseases

Diabetes intensifies the danger of long-term complications. Diabetes increases the risk of cardiovascular diseases such as diabetic cardiomyopathy. The chief complications of diabetes due to injury in small blood vessels comprise damage to the eyes, kidneys, and nerves. Damage to the eyes is known as diabetic retinopathy which is triggered by damage to the blood vessels in the retina of the eye leading to diabetic eye complications. Damage to the kidneys, known as diabetic nephropathy, can pave the way to tissue damaging, urine protein damage, and eventually diabetic nephropathy disease. Diabetes is one of the main cause of kidney failure. At least two third of the people with diabetes may have signs of onset of kidney problems at early stage. Damage to the nerves of the body, known as diabetic neuropathy, is the most common complication of diabetes.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 11: Genetics and Diabetes

Metabolic syndrome and related metabolic traits heritability is relatively high. Genetically altered knockout mice models and human monogenic obese/insulin unaffected syndrome deliver significant molecular insights into the pathogenesis of the metabolic syndrome. Transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function in the body is called as transplantation. It can be of various types such as pancreas transplantation, xenotransplantation and islet transplantation.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 12: Cell Therapy for Diabetes

Cell therapy can be explained as the supervision of live whole cells or maturation of an exact cell population in a patient to overcome the disease. Cell therapy is growing its range of cell types for administration. The treatment strategies of cell therapy comprise separation and transmission of specific stem cell populations, administration of effector cells, induction of mature cells to develop pluripotent cells, and reprogramming of mature cells. The founding of pluripotent human embryonic stem cells and embryonic germ cells have presented a new probable source in type 1 diabetic patients for cell therapy, especially in light of recent successes in generating glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 13: Market analysis of Diabetic products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronic and etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries. 

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Track 14: Emerging Focus on Diabetes Research

Diabetes throws a light in a growing epidemic imposing thoughtful social economic crisis around the nation. Despite scientific innovations and better healthcare research amenities the disease continues to burden numerous segments, especially middle and low income countries. The current trends designate the rise in premature death, posing a major threat to global development. The advancement in science and technology has observed the expansion of newer generation of Nano medicine in drugs discovery. Then, the documentation and clinical investigation of bioactive ingredients from plants have transformed the investigation on drug discovery and lead identification for diabetes management control.

Recommended: Top Diabetes conferences | Endocrinology ConferencesDiabetes Meetings

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 LondonUK; 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy; 3rdMetabolic Syndrome Conferences June 18-19, 2018 DublinIreland; 3rd Public Health and Nutrition Conferences February 26-28, 2018 LondonUK; 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 AmsterdamNetherlands; 13th Healthcare & Technologies Conferences June 14-15, 2018 DublinIreland; 2nd Patient Safety and Quality Healthcare June 21-22, 2018 DublinIreland; 6th Medical Informatics and Telemedicine Conferences July 5-6, 2018 BerlinGermany; 3rd Environmental Health Conferences October 15-16, 2018 WarsawPoland

Related Societies:

USA: American Association of Diabetes Educators | American Diabetes Association | Canadian Diabetes Association | American Association for Clinical Endocrinology | Diabetes Canada

Europe: European Society of Endocrinology | Central European Diabetes Association | FAND - Italian Association of Diabetics | Italian Association for the Defence of the Interests of Diabetics | International Diabetes Federation- Italy

Asia-Pacific: Australian Diabetes Society | Asian Association for the Study of Diabetes | Diabetes Association of Nigeria | Diabetes Association of the Republic of China | Asian Diabetic Association

 

Market Analysis

About the Conference:

With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce 17th Global Diabetes Conference & Nursing Care (Diabetes Global 2018) as a continuum of our previous successful conference. Diabetes Global 2018 will be held in Paris, France during March 08-09, 2018. The conference will focus on Applying Science and Technology to Fight Diabetes.

This conference includes the renowned scientists, geneticist, microbiologists, doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of diabetes, industrial delegates and those using bioinformatics tools for studying under the single roof to discuss and for improving the current therapies, and exploring radical new approaches. The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc.

For more details, please visit: http://globaldiabetes.conferenceseries.com/

Importance & Scope:

The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age. These findings indicate that the “diabetes epidemic” will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.

The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes* among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2012, an estimated 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose. Almost half of all deaths attributable to high blood glucose occur before the age of 70 years1. WHO projects that diabetes will be the 7th leading cause of death in 2030.

Diabetes Global 2018 will feature the latest developments in research, diagonosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique opportunity to network with a wide range of professionals in the field of diabetes technologies and treatments.

   

Societies Associated with Diabetes Research

International Diabetes Federation- Italy

Primary Care Diabetes Society

Australian Diabetes Society

Emirates Diabetes Society

Society for Biomedical Diabetes Research

Immunology of Diabetes Society

American Association of Diabetes Educators

American Diabetes Association

The Asian Association for the Study of Diabetes

International Association of the Diabetes and Pregnancy Study Groups

Diabetes Association of Nigeria

Association of Children's Diabetes Clinicians

Canadian Diabetes Association

FAND - Italian Association of Diabetics

Italian Association for the Defence of the Interests of Diabetics

Association of Diabetes

Association National Italian Diabetic Athletes

Italian Society of Diabetology

Market Value on Diabetic Research:

The impact of diabetes on the individual quality of life and general economy in Italy is substantial. Healthcare costs for patients with diabetes in Italy are estimated at approximately €5.5 billion annually, representing more than 6% of total national healthcare spending. The Cost of Diabetes in Europe—Type 2 Study(CODE-2), which measured the total healthcare costs for patients with type 2 diabetes in 8 European countries (Italy, Belgium, France, Germany, Netherlands, Spain, Sweden, and UK), found the total yearly (1998) costs for people with type 2 diabetes in Italy alone to be almost €5.2 billion, a per-patient expenditure of at least €2900. Among patients with type 2 diabetes in Italy examined by the CODE-2 study, 17.8% were hospitalized during the 6 month study, with an average hospital stay of 13 days. The cost of hospitalizations accounted for the greatest portion of total costs for all countries in the study, at 55%, leading non-antidiabetic drugs (21%), outpatient care (18%) and antidiabetic drugs (7%).[3] Among non-antidiabetic drugs, the majority were cardiovascular and lipid-lowering (42%).[3] Annual per-patient costs vary widely with primary treatment type, with the highest per-patient costs accrued by those treated with diet and exercise alone.

Past Conference Report

Diabetes Global 2017

Diabetes Global 2017 Report

Conference Series LLC takes a great pride in announcing the conclusion of 16th Global Diabetes Conference and Medicare Expo which was held in Rome, Italy, during March 22-23, 2017.

Diabetes Global - 2017 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world. 

The conference aimed a parallel rail with theme “Applying Science and Technology to Fight Diabetes”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like:

Physiology of Diabetes

Diagnosis of Diabetes

Diabetic Case Studies

Treatment of Diabetes

Diabetes in Market

Biomarker for Diabetes

Endocrinology

Diabetes and its Complications

Diabetes and Cardiovascular Diseases

Emerging Focus on Diabetes

Genetics and Diabetes

Market Analysis of Diabetic Products

Diabetic Foot and Ankle

Diabetes and Obesity

Gestational Diabetes

Insulin Management

Diabetes Myths and Statistics

Diabetes and Surgery

Diabetes Retinopathy

Diabetic Nephropathy

The two day event implanted a firm relation of upcoming strategies in the field of Diabetes with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderator David Probst from Arizona State University, USA for his contribution which resulted in smooth functioning of the conference.

We are thankful to our Honourable guests for their generous support and suggestions.

  • Eduardo J Simoes, University of Missouri School of Medicine, USA
  • Mahir Jallo, Thumbay Hospital - Gulf Medical University, UAE
  • Vladimír Štrbák, Slovak Medical University, Slovakia
  • Nicolette N Houreld, University of Johannesburg, South Africa
  • Anna Kokavec, University of New England, Australia
  • P R Raghavan, Nanorx Inc., USA

Symposiums were organized by P R Raghavan (Nanorx Inc., USA) his lecture on “Metadichol®, a novel nano lipid emulsion for the treatment of diabetes” and Dr. Mahir Jallo (Thumbay Hospital - Gulf Medical University, UAE) his lecture on “Glycemic control and weight gain: A critical balance and the impact of the new therapies”.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Diabetes. The highlights of the conference were the keynote forum by prominent scientists, of which the following topics were highlighted:

  • Effect of information technology and informatics on the treatment and control of type 2 diabetes: Eduardo J Simoes, University of Missouri School of Medicine, USA
  • Effect of wine on postprandial serum insulin, plasma glucose, serum IgA and insulin sensitivity as all wines are not the same: Anna Kokavec, University of New England, Australia
  • Direction of insulin to regulatory secretory pathway: Possible role in diabetes mellitus: Vladimír Štrbák, Slovak Medical University, Slovakia
  • Mechanisms of action of photobiomodulation in diabetic wound healing: Nicolette N Houreld, University of Johannesburg, South Africa

The speakers who presented their contributions in the form of highly informative presentations made the conference a top notch one.

Scientific sessions were chaired and co-chaired by: Eduardo J Simoes, University of Missouri School of Medicine, USA; Anna Kokavec, University of New England, Australia; Vladimír Štrbák, Slovak Medical University, Slovakia; Nicolette N Houreld, University of Johannesburg, South Africa.

We congratulate Dr. Sharifa Ali Abdulrahman Hashem from United Arab Emirates University, UAE for winning the Young Research Forum award.

ConferenceSeries LLC has taken the privilege of felicitating Diabetes Global 2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Diabetes Global Conference. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Diabetes and Metabolism-Open Access as a special issue.

Conference Series LLC offers its heartfelt appreciation to the Collaborators ComtecMed Medical Conferences and Main Media Partners Glycosmedia and EIN Presswire who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the conference, ConferenceSeries LLC would like to proudly announce the commencement of the "17th Global Diabetes Conference and Nursing Care" to be organized during March 8-9, 2018 at Paris, France.

The success of the International Conference on Diabetes Global 2017 has given us the prospect to bring the gathering one more time, ConferenceSeries LLC hosted the 16th Global Diabetes Conference and Medicare Expo which was held in Rome, Italy, during March 22-23, 2017.

Mark your calendars for the upcoming conference; we hope to see you soon!


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 8-9, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Diabetes and Metabolism Pancreatic Disorders and Therapy Journal of Steroids and Hormonal Science

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner